Merck to Acquire Terns Pharmaceuticals in $6.7 Billion Deal

Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu

-Michelle Davis, Bloomberg News Senior Deals Reporter, discusses Merck agreeing to buy Terns Pharmacueticals for $6.7 billion, giving the company access to a promising new leukemia treatment. The acquisition is expected to close in the second quarter, with Merck paying $53 per share in cash for Terns, a 6% premium to its closing price on Tuesday.

-Geetha Ranganathan, Bloomberg Intelligence Analyst on US Media, discusses the latest at Walt Disney and Netflix. Walt Disney Co. Chief Executive Officer Josh D’Amaro has seen two billion-dollar technology bets falter, with one of them unraveling entirely, just days into his new job. Separately, Netflix Inc.'s push into livestreaming mega events in Asia is set to accelerate, buoyed by hits from the World Baseball Classic to BTS's comeback show.

-Diana Rosero Pena, Bloomberg Intelligence Consumer Staples Analyst, discusses Chewy earnings. Chewy forecast sales for the year that beat analyst estimates, suggesting the online pet retailer expects strong demand to more than make up for headwinds including inflation and tariff uncertainty.

-Justin Pridon, VP, Consulting Services at Revenue Management Solutions, discusses restaurant trends from the BI Farm, Food & Fuel Conference. He talks about what restaurant menus reveal about where food demand is headed, why protein is winning, and how demand might change with rising gas prices.

See omnystudio.com/listener for privacy information.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(3409)

Vertical's Dillon on IP Buying WY Pulp Asset: 'Win Win' (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010Chip Dillon, Partner and Head of Global Paper and Packaging Practice at Vertical Research Partners, on International...

2 Mai 20164min

Bloomberg's Leonard on New Book, 'Neither Snow Nor Rain'(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Bloomberg Businessweek writer Devin Leonard on his new book "NEITHER SNOW NOR RAIN," a landmark century-spanning social, political, ...

2 Mai 201611min

ISM's Holcomb: Companies Continuing to Cut Inventories (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Brad Holcomb, Chairman of the Manufacturing Business Survey at the Institute for Supply Management, on the April ISM report.See omny...

2 Mai 20168min

Bloomberg's Chappatta on Puerto Rico's Imminent Default (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Brian Chappatta, Municipal Bond Reporter for Bloomberg news, on which Puerto Rico bond may default next, as the next payment deadlin...

29 Apr 20168min

Bloomberg's Wilson on Winners, Losers, Stock of the Day (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Bloomberg stocks editor David Wilson on today's market winners, losers, and Stock of the Day: Enova International (ENVA).See omnystu...

29 Apr 201612min

S&P's Stovall Says Better Off Rotating Than Retreating (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Sam Stovall, US Equity Strategist for S&P Capital IQ, for a look at the US stock market and his current investment strategies.See om...

29 Apr 201611min

Cushing's Toudouze: Big Energy Companies Need to Adapt (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Libby Toudouze, Partner and Portfolio Manager at Cushing Asset Management, on Exxon and Chevron earnings.See omnystudio.com/listener...

29 Apr 201611min

Coravin's Lambrecht on Pouring Wine Without Pulling Cork(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Greg Lambrecht Founder & Chairman of Coravin, on their technology that allows you to pour your favorite wine by the glass without pu...

29 Apr 20168min